«

»

RegenXBio Gene Therapy Shows Early Promise Eye Disease; Cholesterol Treatment Results Mixed

A gene therapy being developed by RegenX Bio of Rockville, MD, showed early promise against wet macular degeneration, a leading cause of blindness.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive